REVVITY, INC Gain (Loss) on Extinguishment of Debt
REVVITY, INC (RVTY) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-24
- REVVITY, INC gain (loss) on extinguishment of debt for the quarter ending 2024-12-29 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC gain (loss) on extinguishment of debt for the quarter ending 2024-09-29 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was $0.00.
- REVVITY, INC gain (loss) on extinguishment of debt for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- REVVITY, INC gain (loss) on extinguishment of debt for fiscal 2025 was $0.00.
- REVVITY, INC gain (loss) on extinguishment of debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- REVVITY, INC gain (loss) on extinguishment of debt for fiscal 2023 was $3.69M, a 27.95% increase from fiscal 2023.
- REVVITY, INC gain (loss) on extinguishment of debt for fiscal 2023 was $2.88M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-28 | $0.00 10-K · filed 2026-02-24 | ||||
| 2024-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | |
| 2024-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $263.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $263.00K derived: sum of 3 quarters · filed 2026-02-24 | $340.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $263.00K derived: sum of 2 quarters · filed 2026-02-24 | $340.00K derived: sum of 3 quarters · filed 2026-02-24 | $340.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $340.00K derived: sum of 2 quarters · filed 2026-02-24 | $340.00K derived: sum of 3 quarters · filed 2026-02-24 | $3.69M 10-K · filed 2026-02-24 | |
| 2023-10-01 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $77.00K derived: sum of 2 quarters · filed 2024-11-06 | $3.42M 10-Q · filed 2024-11-06 | $6.21M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.35M 10-Q · filed 2024-08-06 | $6.13M derived: sum of 3 quarters · filed 2025-02-25 | $6.71M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-04-02 | $3.35M 10-Q · filed 2024-05-07 | $6.13M derived: sum of 2 quarters · filed 2025-02-25 | $6.71M derived: sum of 3 quarters · filed 2025-02-25 | $6.34M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-01-01 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $3.37M derived: sum of 2 quarters · filed 2025-02-25 | $3.00M derived: sum of 3 quarters · filed 2025-02-25 | $2.88M 10-K · filed 2025-02-25 | -$2.88M 10-K · filed 2023-03-01 |
| 2022-10-02 | $580.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $211.00K derived: sum of 2 quarters · filed 2023-11-07 | $92.00K 10-Q · filed 2023-11-07 | ||
| 2022-07-03 | -$369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$488.00K 10-Q · filed 2023-08-09 | |||
| 2022-04-03 | -$119.00K 10-Q · filed 2023-05-12 | ||||
| 2022-01-02 | $0.00 10-K · filed 2023-03-01 | ||||
| 2021-01-03 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | ||
| 2020-10-04 | $0.00 10-Q · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | |||
| 2019-12-29 | $32.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $32.54M derived: sum of 2 quarters · filed 2022-03-03 | $32.54M 10-K · filed 2022-03-03 | ||
| 2019-09-29 | $471.00K 10-Q · filed 2020-11-10 | $471.00K 10-Q · filed 2020-11-10 | |||
| 2018-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $0.00 derived: sum of 2 quarters · filed 2021-03-02 | $0.00 10-K · filed 2021-03-02 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |